Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baizi Yangxin Wan
- Development stage
- Unknown
- Lead developer
- Shanghai Guangsheng Pharmaceutical
- Modality
- Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Baizi Yangxin Wan is a traditional Chinese medicine (TCM) formulation manufactured by Shanghai Guangsheng Pharmaceutical (also known as Shanghai Huayuan Pharmaceutical Anhui Guangsheng Pharmaceutical). It is a multi-herb remedy composed of ingredients including Biota seed (Bai Zi Ren), Dang Shen, Huang Qi, Chuan Xiong, Dang Gui, Fu Ling, Yuan Zhi, Suan Zao Ren, Rou Gui, Wu Wei Zi, Ban Xia Qu, Gan Cao, and Cinnabaris (Zhu Sha). According to TCM principles, the formulation is designed to replenish qi and blood and induce sedation. It is primarily indicated for conditions associated with heart deficiency, such as cardiac palpitations, insomnia, dream-disturbed sleep, forgetfulness, and susceptibility to fright. As a traditional herbal product, it lacks a single defined molecular target and instead relies on the synergistic effects of its constituent botanical and mineral components.
- Other names
- 柏子養心丸柏子养心丸Baizi Yangxin Pill
Beyond the preview
Go deeper on Baizi Yangxin Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baizi Yangxin Wan.